The ROE (Return on Equity) of Acceleron Pharma Inc (XLRN) is -19.42%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2020-12-31 | -19.42% |
| 2019-12-31 | -27.78% |
| 2018-12-31 | -40.71% |
| 2017-12-31 | -29.70% |
| 2016-12-31 | -25.27% |
| 2015-12-31 | -58.45% |
| 2014-12-31 | -32.80% |
| 2013-12-31 | -37.89% |
| 2012-12-31 | 145.45% |
| 2011-12-31 | 407.53% |